HIV 진단 시장 규모, 점유율 및 성장 분석 : 검사 유형별, 제품 유형별, 기술별, 최종사용자별, 지역별 - 업계 예측(2026-2033년)

Global HIV Diagnostics Market size was valued at USD 3.4 billion in 2024 and is poised to grow from USD 3.55 billion in 2025 to USD 5.05 billion by 2033, growing at a CAGR of 4.5% during the forecast period (2026-2033).

The global HIV diagnostics market is poised for substantial growth, driven by the rising prevalence of HIV infections and the heightened demand for accurate and timely diagnostic solutions. Key factors propelling this market include advancements in point-of-care testing technologies and increased government initiatives aimed at promoting HIV awareness and testing. The introduction of rapid testing kits and the expansion of molecular diagnostic methods are enhancing market reach. While North America maintains a dominant market share due to robust healthcare infrastructure and high testing rates, the Asia-Pacific region is anticipated to exhibit the fastest growth, supported by improved healthcare access and public policy initiatives. Despite these positive trends, challenges such as high diagnostic costs, accessibility issues in low-income regions, and lingering stigma surrounding HIV testing could impede broader market adoption.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global HIV Diagnostics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global HIV Diagnostics Market Segments Analysis

Global HIV Diagnostics Market is segmented by Test Type, Product Type, Technology, End User and region. Based on Test Type, the market is segmented into Antibody Tests, Antigen Tests and Nucleic Acid Tests. Based on Product Type, the market is segmented into Tests Kits, Instruments and Software. Based on Technology, the market is segmented into Elisa, Rapid Testing and Polymerase Chain Reaction. Based on End User, the market is segmented into Hospitals, Diagnostic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global HIV Diagnostics Market

The global HIV diagnostics market is experiencing robust growth due to a notable rise in HIV cases worldwide. This surge in infections has intensified the demand for dependable, early, and precise diagnostic solutions. In response to this pressing need, healthcare providers and governmental organizations have ramped up their screening initiatives, effectively driving market expansion. Furthermore, this proactive approach not only fosters advancements in diagnostic technology but also supports sustained growth in various regions, ensuring that healthcare systems are better equipped to address the challenges posed by the increasing prevalence of HIV.

Restraints in the Global HIV Diagnostics Market

The Global HIV Diagnostics market faces significant challenges due to the prohibitive costs associated with modern testing technologies, which, despite their ability to provide early and accurate results, remain out of reach for many, particularly in lower- and middle-income countries. Advanced testing methods, such as nucleic acid testing and automated systems, demand considerable investment in infrastructure and skilled personnel. This financial burden restricts the widespread adoption of these innovative diagnostics, hindering their integration into healthcare systems. Consequently, this limitation not only impacts the pace of market growth but also deepens disparities in access to essential diagnostic services worldwide.

Market Trends of the Global HIV Diagnostics Market

The global HIV diagnostics market is witnessing a significant trend towards the growing adoption of HIV self-testing kits. These kits offer a convenient, private, and affordable option for individuals, making them particularly appealing in regions where social stigma surrounding HIV persists or where healthcare infrastructure is lacking. By allowing users to receive results in the comfort of their homes, self-testing kits enhance awareness and facilitate early diagnosis, effectively encouraging more people to get tested. This shift towards self-testing, characterized by affordability and ease of use, is driving substantial growth and expanding access to HIV diagnostics on a global scale.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Regulatory Landscape
• Technology Assessment

Global HIV Diagnostics Market Size by Test Type & CAGR (2026-2033)

• Market Overview
• Antibody Tests
• Antigen Tests
• Nucleic Acid Tests

Global HIV Diagnostics Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Tests Kits
• Instruments
• Software

Global HIV Diagnostics Market Size by Technology & CAGR (2026-2033)

• Market Overview
• Elisa
• Rapid Testing
• Polymerase Chain Reaction

Global HIV Diagnostics Market Size by End-User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Laboratories
• Home Care Settings

Global HIV Diagnostics Market Size & CAGR (2026-2033)

• North America (Test Type, Product Type, Technology, End-User)
  • US
  • Canada
• Europe (Test Type, Product Type, Technology, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Test Type, Product Type, Technology, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Test Type, Product Type, Technology, End-User)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Test Type, Product Type, Technology, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Abbott Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OraSure Technologies, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Grifols, S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Chembio Diagnostic Systems, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Trinity Biotech plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioLytical Laboratories Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Atomo Diagnostics
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SD Biosensor, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• J. Mitra & Co. Pvt. Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• MedMira Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations